Flush with $126M raise, Tes­sa Ther­a­peu­tics woos new CEO from Take­da

Af­ter some repo­si­tion­ing — and a $126 mil­lion fi­nanc­ing round to take it down that di­rec­tion — Sin­ga­pore’s Tes­sa Ther­a­peu­tics has found a new cap­tain to steer the ship.

Thomas Willem­sen is jump­ing from Take­da, where he was most re­cent­ly SVP, Asia-Pa­cif­ic, to spear­head Tes­sa’s dri­ve to de­vel­op new CAR-T ther­a­pies, in­clud­ing both au­tol­o­gous and off-the-shelf ones.

As pres­i­dent and CEO, Willem­sen will be in charge of “cor­po­rate, busi­ness and de­vel­op­ment strat­e­gy,” the com­pa­ny added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER